BCR and neoplasm: The BCR-ABL1 fusion gene encodes the BCR-ABL1 protein, which exhibits potent tyrosine kinase activity, that leads to abnormal signal pathway activation, rapid tumor cell proliferation, and inhibition of apoptosis.